TrialCancer immunology, immunotherapy : CII2006

A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic melanoma patients.

Lorenzo Pilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.